By Lindsey Collins, T.J. Benedict and Ann O’Brien ( September 4, 2026, 2:25 PM EDT) -- In ongoing multidistrict antitrust litigation alleging price-fixing by numerous generic-drug manufacturers, the U.S. District Court for the Eastern District of Pennsylvania issued a significant opinion on July 27 with direct implications for any company that has entered or may enter into a deferred prosecution agreement with the U.S. Department of Justice....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.